Scynexis (SCYX) EPS (Basic) (2013 - 2026)
Scynexis' (SCYX) quarterly EPS (Basic) came in at -$0.6 in Q2 2026, up 45.84% on a YoY basis from -$0.41 in Q2 2025, and up 76.72% quarter-over-quarter from -$2.58 in Q1 2026.
Powered by 
Analysis
Scynexis (SCYX) EPS (Basic) (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has reported EPS (Basic) for 14 consecutive years, with -$0.6 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 45.84% year-over-year to -$0.6; the trailing twelve-month figure through Jun 2026 stood at -$1.52 (up 36.51% YoY), and the FY2025 full-year result was -$1.09, up 60.42% from the prior year.
- EPS (Basic) climbed to -$0.6 in Q2 2026 per SCYX's latest filing, from -$2.58 in the prior quarter.
- Across five years, EPS (Basic) topped out at $20.45 in Q2 2023 and bottomed at -$5.67 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.45 across 5 years, with a median of -$1.11 in 2022.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) sank 2639.84% in 2022, then soared 8603.16% in 2025.
- Over 5 years, EPS (Basic) stood at -$1.12 in 2022, then slumped by 401.65% to -$5.61 in 2023, then surged by 100.46% to $0.03 in 2024, then soared by 8603.16% to $2.25 in 2025, then sank by 126.61% to -$0.6 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.6, -$2.58, and $2.25 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | -0.60 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.60 |
| Mar 31, 2026 | -2.58 |
| Dec 31, 2025 | 2.25 |
| Sep 30, 2025 | -1.38 |
| Jun 30, 2025 | -1.11 |
| Mar 31, 2025 | -0.87 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | -0.46 |
| Jun 30, 2024 | -2.38 |
| Mar 31, 2024 | 0.07 |
| Dec 31, 2023 | -5.61 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | 20.45 |
| Mar 31, 2023 | -5.67 |
| Dec 31, 2022 | -1.12 |
| Sep 30, 2022 | -4.98 |
| Jun 30, 2022 | -2.47 |
| Mar 31, 2022 | -1.36 |
| Dec 31, 2021 | -7.46 |
| Sep 30, 2021 | -0.18 |